Product Overview

Contimira S 50 is a combination formulation containing Mirabegron Extended Release 50 mg and Solifenacin Succinate IP 5 mg, developed for the effective management of Overactive Bladder (OAB). By combining a β3-adrenoceptor agonist with an antimuscarinic agent, it provides a comprehensive treatment approach that helps reduce urinary urgency, increased urinary frequency, and urge urinary incontinence.

The extended-release formulation of Mirabegron offers sustained bladder relaxation during the storage phase, while Solifenacin helps minimize involuntary bladder contractions. Together, these complementary actions improve bladder capacity, reduce bothersome urinary symptoms, and support better bladder control throughout the day.

Contimira S 50 is suitable for patients who require combination therapy for improved symptom management and is intended to enhance comfort, confidence, and overall quality of life while supporting long-term management of Overactive Bladder.

How It Works

Contimira S 50 combines two proven therapeutic mechanisms. Mirabegron stimulates β3-adrenergic receptors in the bladder, relaxing the detrusor muscle during urine storage and increasing bladder capacity. Solifenacin Succinate blocks muscarinic receptors responsible for involuntary bladder contractions, helping reduce urinary urgency, frequency, and urge incontinence. Together, they provide enhanced symptom control compared to either therapy alone in appropriate patients.

Therapeutic Applications

Contimira S 50 may be prescribed for the management of:

• Overactive Bladder (OAB)
• Urinary Urgency
• Increased Urinary Frequency
• Urge Urinary Incontinence
• Mixed Overactive Bladder Symptoms
• Patients requiring combination therapy as determined by the treating physician

Key Benefits

• Dual-action therapy for comprehensive OAB management.
• Helps reduce urinary urgency and frequency.
• Improves bladder capacity and urinary control.
• Extended-release formulation for sustained therapeutic action.
• Supports improved quality of life and daily comfort.
• Manufactured under stringent pharmaceutical quality standards.

Quality Commitment

Vinix Biopharma is committed to delivering high-quality urology products manufactured under stringent pharmaceutical quality standards. Contimira S 50 undergoes rigorous quality control at every stage of production to ensure safety, consistency, efficacy, and reliability, providing healthcare professionals and patients with trusted therapeutic solutions.

Storage Information

Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Disclaimer

Contimira S 50 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition and therapeutic requirements.